RECK Inhibits Stemness Gene Expression and Tumorigenicity of Gastric Cancer Cells by Suppressing ADAM-Mediated Notch1 Activation

作者: Kun-Jing Hong , Deng-Chyang Wu , Kuang-Hung Cheng , Li-Tzong Chen , Wen-Chun Hung

DOI: 10.1002/JCP.24434

关键词:

摘要: The Reversion-inducing Cysteine-rich Protein with Kazal Motifs (RECK) gene encodes a membrane-anchored glycoprotein that exhibits strong inhibitory activity against various matrix metalloproteinases (MMPs) and disintegrin metalloproteinase 10 (ADAM10). RECK functions as tumor suppressor by inhibiting migration, invasion, angiogenesis. However, whether can modulate the stem-like phenotypes of cancer cells is not known. In this study, we demonstrate down-regulated in gastric further reduced CD133-positive cells. Ectopic expression induces down-regulation stemness genes including Sox2, Oct4, Nanog stem cell marker CD133. Treatment DAPT (a γ-secretase inhibitor) or TAPI-2 hydroxamate-based inhibitor MMPs, necrosis factor α converting enzyme ADAM17) reduces Notch1 shedding activation which results attenuation Our data show ADAM10 ADAM17 are co-pulled down suggesting physical interaction between ADAMs on surface. addition, suppresses sphere formation size Overexpression Notch intracellular domain (NICD) effectively reverse effect More importantly, tumorigenic vivo. Conversely, knockdown non-tumorigenic GI2 increases CD133 forming ability. Collectively, these indicate represses properties ADAM-mediated activation. J. Cell. Physiol. 229: 191–201, 2014. © 2013 Wiley Periodicals, Inc.

参考文章(51)
Joshua C. Curtin, Matthew V. Lorenzi, Drug Discovery Approaches to Target Wnt Signaling in Cancer Stem Cells Oncotarget. ,vol. 1, pp. 563- 577 ,(2010) , 10.18632/ONCOTARGET.191
C R Jeter, B Liu, X Liu, X Chen, C Liu, T Calhoun-Davis, J Repass, H Zaehres, J J Shen, D G Tang, NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation Oncogene. ,vol. 30, pp. 3833- 3845 ,(2011) , 10.1038/ONC.2011.114
S Kitajima, T Miki, Y Takegami, Y Kido, M Noda, E Hara, A Shamma, C Takahashi, Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling Oncogene. ,vol. 30, pp. 737- 750 ,(2011) , 10.1038/ONC.2010.448
Yue Zhang, Shaoqiang Cheng, Guoqiang Zhang, Wenjie Ma, Yang Liu, Rui Zhao, Qingyuan Zhang, Da Pang, Low expression of RECK indicates a shorter survival for patients with invasive breast cancer. Cancer Science. ,vol. 103, pp. 1084- 1089 ,(2012) , 10.1111/J.1349-7006.2012.02265.X
Zhiwei Wang, Yiwei Li, Aamir Ahmad, Asfar S. Azmi, Sanjeev Banerjee, Dejuan Kong, Fazlul H. Sarkar, Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochimica et Biophysica Acta. ,vol. 1806, pp. 258- 267 ,(2010) , 10.1016/J.BBCAN.2010.06.001
Wei He, Ke Li, Feng Wang, Yan-Ru Qin, Qing-Xia Fan, Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis World Journal of Gastroenterology. ,vol. 18, pp. 712- 719 ,(2012) , 10.3748/WJG.V18.I7.712
Jeffrey A. Magee, Elena Piskounova, Sean J. Morrison, Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty Cancer Cell. ,vol. 21, pp. 283- 296 ,(2012) , 10.1016/J.CCR.2012.03.003
T. Mizutani, Y. Taniguchi, T. Aoki, N. Hashimoto, T. Honjo, Conservation of the biochemical mechanisms of signal transduction among mammalian Notch family members. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 98, pp. 9026- 9031 ,(2001) , 10.1073/PNAS.161269998
Domenico Ribatti, Cancer stem cells and tumor angiogenesis Cancer Letters. ,vol. 321, pp. 13- 17 ,(2012) , 10.1016/J.CANLET.2012.02.024
Zheng Wang, Efrat Oron, Brynna Nelson, Spiro Razis, Natalia Ivanova, Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells Cell Stem Cell. ,vol. 10, pp. 440- 454 ,(2012) , 10.1016/J.STEM.2012.02.016